Maria Rosaria De Paolis

Early Use of Thrombopietin Receptor Agonists (Tpo-Ras) in Clinical Practice: Results from an Italian Survey on Behalf of the Gimema Working Group Anemia and Thrombocytopenia.

Mariasanta Napolitano, Elisa Lucchini, Maria Rosaria De Paolis

N/A

es, it (code pays fourni par la source)

Identification of Novel Mutations in Patients Affected by Gaucher Disease

M.C. Anania, Miriam Giacomarra, Annalisa D’Errico, Massimo Marano et autres

Gaucher disease is an autosomal recessive disorder caused by dysfunction of the enzyme glucocerebrosidase. The enzyme deficiency is mainly due to mutations in the GBA1 gene, and it is responsible for the accumulation of glucosylceramide within the lysosomes of monocyte macrophage-derived cells; …

it (code pays fourni par la source)

Evans syndrome: Disease awareness and clinical management in a nation‐wide ITP ‐ NET survey

Bruno Fattizzo, Valentina Carrai, Monica Crugnola, Erminia Baldacci et autres

Evans syndrome (ES) is rare and mostly treated on a "case-by-case" basis and no guidelines are available. With the aim of assessing disease awareness and current management of adult ES, a structured survey was administered to 64 clinicians from 50 Italian participating …

it (code pays fourni par la source)

Corrigendum: Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences

Bernardo Rossini, Nicola Cecchi, Felice Clemente, Maria Rosaria De Paolis et autres

The authors wish to make the following corrections to their article: Rossini B, Cecchi N, Clemente F, De Paolis MR, Hohaus S, Innao V, Lucignano M, Massaiu R, Palumbo G, Rigolin GM, Rossi FG, Verga L, Guarini A. Real-practice management and treatment …

The evolving landscape of COVID ‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC , the European research initiative on CLL

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, Anargyros Kapetanakis et autres

In this retrospective international multicenter study, we describe the clinical characteristics and outcomes of patients with chronic lymphocytic leukemia (CLL) and related disorders (small lymphocytic lymphoma and high-count monoclonal B lymphocytosis) infected by SARS-CoV-2, including the development of post-COVID condition. Data from …

it, gr, gb, es, ch, rs, se, be, cz, de, us, Égypte, ar, dk, pt, il, hr, ru, pl, nl, in, ro, np (code pays fourni par la source)

PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANAGEMENT IN A NATION-WIDE ITALIAN SURVEY

Bruno Fattizzo, Valentina Carrai, Monica Crugnola, Erminia Baldacci et autres

Topic: 32. Platelet disorders Background: Evans syndrome (ES) is defined by the concomitant or subsequent association of two or more immune cytopenias, namely autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), and chronic idiopathic/autoimmune neutropenia (CIN/AIN). ES management is not standardized. Aims: To …

it (code pays fourni par la source)

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study

Francesco Autore, Idanna Innocenti, Gianluigi Reda, Andrea Visentin et autres

Clinical or biological parameters useful to predict progression during treatment in real-life setting with ibrutinib, idelalisib and venetoclax in relapsed/refractory chronic lymphocytic leukemia (CLL) are still debated. We conducted a multi-center retrospective study on CLL patients treated with ibrutinib and/or idelalisib who …

it, us (code pays fourni par la source)

Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study

Andrea Visentin, Lydia Scarfò, Thomas Chatzikonstantinou, Anargyros Kapetanakis et autres

BACKGROUND. Infection by SARS-CoV2 remains a worldwide health burden. Previous studies by the ERIC (European Research Initiative on CLL) showed that patients with chronic lymphocytic leukemia (CLL) have a very-high risk of severe Coronavirus disease 19 (COVID19). In particular, age, CLL-directed treatment, …

it, gr, ch, rs, gb, es, be, cz, Égypte, ar, de, pt, il, hr, ru, nl, in, se, pl, dk, ro, np, ie (code pays fourni par la source)

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

Darko Antić, Nataša Milić, Thomas Chatzikonstantinou, Lydia Scarfò et autres

Background: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was …

rs, gr, it, gb, es, ch, cz, Égypte, ar, pt, il, de, hr, be, ru, pl, nl, in, ro, np, ca (code pays fourni par la source)

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

Darko Antić, Nataša Milić, Thomas Chatzikonstantinou, Lydia Scarfò et autres

BACKGROUND: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was …

rs, gr, it, gb, es, ch, cz, Égypte, ar, pt, il, de, hr, be, ru, pl, nl, in, ro, np, qa, ca (code pays fourni par la source)

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and COVID-19: A study of ERIC, the European Research Initiative on CLL

Darko Antić, Nataša Milić, Thomas Chatzikonstantinou, Lydia Scarfò et autres

Abstract Background: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. In this retrospective multicenter study, …

rs, gr, it, gb, es, ch, cz, Égypte, ar, pt, il, ru, de, hr, be, pl, nl, in, Gabon, us, ie, ro, np, qa, ca (code pays fourni par la source)

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis et autres

Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome and elucidate the impact of CLL-directed treatments on the course of COVID-19. …

gr, it, gb, es, ch, rs, se, be, cz, de, Égypte, ar, dk, pt, il, hr, ru, pl, nl, in, ro, np (code pays fourni par la source)